ST Pharm Co.,Ltd. 237690.KQ Stock
ST Pharm Co.,Ltd. Price Chart
ST Pharm Co.,Ltd. 237690.KQ Financial and Trading Overview
| ST Pharm Co.,Ltd. stock price | 83200 KRW |
| Previous Close | 81300 KRW |
| Open | 81800 KRW |
| Bid | 80700 KRW x 0 |
| Ask | 80800 KRW x 0 |
| Day's Range | 80500 - 82500 KRW |
| 52 Week Range | 69400 - 117400 KRW |
| Volume | 73.73K KRW |
| Avg. Volume | 115.36K KRW |
| Market Cap | 1.51T KRW |
| Beta (5Y Monthly) | 0.90909 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 120727 KRW |
237690.KQ Valuation Measures
| Enterprise Value | 1.57T KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.502959 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 7.82 |
| Enterprise Value/EBITDA | 66.921 |
Trading Information
ST Pharm Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | 0.90909 |
| 52-Week Change | -7.29% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 117400 KRW |
| 52 Week Low | 69400 KRW |
| 50-Day Moving Average | 84134 KRW |
| 200-Day Moving Average | 82791.5 KRW |
237690.KQ Share Statistics
| Avg. Volume (3 month) | 115.36K KRW |
| Avg. Daily Volume (10-Days) | 81.67K KRW |
| Shares Outstanding | 18.66M |
| Float | 10.06M |
| Short Ratio | N/A |
| % Held by Insiders | 47.98% |
| % Held by Institutions | 14.06% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 5.47% |
| Operating Margin (ttm) | 4.01% |
| Gross Margin | 35.30% |
| EBITDA Margin | 11.68% |
Management Effectiveness
| Return on Assets (ttm) | 0.98% |
| Return on Equity (ttm) | 3.25% |
Income Statement
| Revenue (ttm) | 200.66B KRW |
| Revenue Per Share (ttm) | 10690.27 KRW |
| Quarterly Revenue Growth (yoy) | 31.39% |
| Gross Profit (ttm) | 55.31B KRW |
| EBITDA | 23.45B KRW |
| Net Income Avi to Common (ttm) | 10.98B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | 35.89% |
Balance Sheet
| Total Cash (mrq) | 66.19B KRW |
| Total Cash Per Share (mrq) | 3519.25 KRW |
| Total Debt (mrq) | 129.14B KRW |
| Total Debt/Equity (mrq) | 38.38 KRW |
| Current Ratio (mrq) | 2.941 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.97B KRW |
| Levered Free Cash Flow (ttm) | -59919900672 KRW |
Profile of ST Pharm Co.,Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | MSA Building |
| ZIP | 06194 |
| Phone | 82 2 527 6373 |
| Website | https://www.stpharm.co.kr |
| Industry | |
| Sector(s) | |
| Full Time Employees | 566 |
ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.
Q&A For ST Pharm Co.,Ltd. Stock
What is a current 237690.KQ stock price?
ST Pharm Co.,Ltd. 237690.KQ stock price today per share is 83200 KRW.
How to purchase ST Pharm Co.,Ltd. stock?
You can buy 237690.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ST Pharm Co.,Ltd.?
The stock symbol or ticker of ST Pharm Co.,Ltd. is 237690.KQ.
How many shares does ST Pharm Co.,Ltd. have in circulation?
The max supply of ST Pharm Co.,Ltd. shares is 18.66M.
What is ST Pharm Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
ST Pharm Co.,Ltd. PE Ratio is now.
What was ST Pharm Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
ST Pharm Co.,Ltd. EPS is 0 KRW over the trailing 12 months.
ST Pharm Co.,Ltd. 237690.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq 100 Index KQ100 | 2012.77 KRW 1.52 USD |
-1.23
|
37.53K KRW 28 USD | 1997.54 KRW 1.51 USD | 2024.99 KRW 1.53 USD | — - | 37.53K KRW 28 USD |
| Kosdaq Pharmaceuticals Index KQ26 | 9230.64 KRW 6.97 USD |
-0.48
|
22.23K KRW 17 USD | 9102.9 KRW 6.87 USD | 9268.21 KRW 7 USD | — - | 22.23K KRW 17 USD |
- {{ link.label }} {{link}}